Periodic Reporting for period 1 - GAIT (From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy)

Summary
The annual increase in prevalence of allergy related diseases develops at an alarming pace worldwide. Responsible disease mechanisms are characterised by unwanted immune responses to substances which do not harm healthy individuals. The allergy therapeutics market is now...
More information & hyperlinks